Evidence map›Paper›PMID 21614544›Full record

ArticleParasitology research2012

Anti-malarial, anti-trypanosomal, and anti-leishmanial activities of jacaranone isolated from Pentacalia desiderabilis (Vell.) Cuatrec. (Asteraceae).

Thiago R Morais, Paulete Romoff, Oriana A Fávero, Juliana Q Reimão, Walkyria C Lourenço, André G Tempone, Angelica D Hristov, Silvia M Di Santi, João Henrique G Lago, Patricia Sartorelli and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Synthesis and Antimicrobial Activity of the PathogenicInternational journal of molecular sciences · 2023
    Article
  3. The Potentials ofInfection and drug resistance · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Antiobesity Effects of Hydroethanolic Extract ofEvidence-based complementary and alternative medicine : eCAM · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Thiago R MoraisCentro de Ciências e Humanidades e Centro de Ciências Biológias e da Saúde, Universidade Presbiteriana Mackenzie, 01302-907, São Paulo, SP, Brazil.
Paulete Romoff
Oriana A Fávero
Juliana Q Reimão
Walkyria C Lourenço
André G Tempone
Angelica D Hristov
Silvia M Di Santi
João Henrique G Lago
Patricia Sartorelli
Marcelo J P Ferreira
Universidade Presbiteriana Mackenzie · BRInstituto Adolfo Lutz · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis, Chagas disease, and malaria affect the poorest population around the world, with an elevated mortality and morbidity. In addition, the therapeutic alternatives are usually toxic or ineffective drugs especially those against the trypanosomatids. In the course of selection of new anti-protozoal compounds from Brazilian flora, the CH(2)C(l2) phase from MeOH extract obtained from the leaves of Pentacalia desiderabilis (Vell.) Cuatrec. (Asteraceae) showed in vitro anti-leishmanial, anti-malarial, and anti-trypanosomal activities. The chromatographic fractionation of the CH(2)Cl(2) phase led to the isolation of the bioactive compound, which was characterized as jacaranone [methyl (1-hydroxy-4-oxo-2,5-cyclohexandienyl)acetate], by spectroscopic methods. This compound showed activity against promastigotes of Leishmania (L.) chagasi, Leishmania (V.) braziliensis, and Leishmania (L.). amazonensis showing an IC(50) of 17.22, 12.93, and 11.86 μg/mL, respectively. Jacaranone was also tested in vitro against the Trypanosoma cruzi trypomastigotes and Plasmodium falciparum chloroquine-resistant parasites (K1 strain) showing an IC(50) of 13 and 7.82 μg/mL, respectively, and was 3.5-fold more effective than benznidazole in anti-Trypanosoma cruzi assay. However, despite of the potential against promatigotes forms, this compound was not effective against amastigotes of L. (L.) chagasi and T. cruzi. The cytotoxicity study using Kidney Rhesus monkey cells, demonstrated that jacaranone showed selectivity against P. falciparum (21.75 μg/mL) and a selectivity index of 3. The obtained results suggested that jacaranone, as other similar secondary metabolites or synthetic analogs, might be useful tolls for drug design for in vivo studies against protozoan diseases.

Indexed as

AnimalsAntiprotozoal AgentsAsteraceaeBenzoquinonesBrazilCell LineCell SurvivalChromatographyInhibitory Concentration 50LeishmaniaMacaca mulattaPlant ExtractsPlant LeavesPlasmodium falciparumSpectrum AnalysisTrypanosoma cruziAntiprotozoal AgentsBenzoquinonesjacaranonePlant Extracts

Identifiers

PMID21614544
OpenAlexW2007041021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.